© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
June 28, 2021
Patients with cancer who are treated with checkpoint inhibitors or immunotherapy, along with other treatments, run the risk of developing ILD as a side effect.
June 25, 2021
From the Chairman
Thanks to ongoing research and clinical trials, it seems that there are always new immunotherapies emerging.
June 21, 2021
On behalf of the Head and Neck Cancer Alliance, Dr. Michael Moore spoke with CURE® about emerging therapies that potentially offer exciting new options for the future.
June 18, 2021
One expert tells patients to ‘hang tight’ as immunotherapy options are getting better each year.
June 17, 2021
Research News and Updates
Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.
June 16, 2021
BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.
June 15, 2021
First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.
Experts urge patients to stop playing the wait-and-see game: There’s no ‘playbook’ for immunotherapy-related toxicities, and side effects can be managed if caught early.
June 14, 2021
To avoid the financial burden of costly therapies, patients with cancer receiving immunotherapy treatments should talk with their health care team and not settle for no as an answer from their health insurance provider, according to an expert.
Novel App Informs Patients With Cancer of Unknown Primary
Giving Hope: Research on Rare Head and Neck Cancer Treatment Options
Searching For My Cancer Words
Pain Management Has Worsened for Patients With Late-Stage Cancer